Humira(CF) pen 80 MG/0.8 MLS
Ended Awarded
- Contract number
- SPE2DB25FE4B8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,617
Award facts
- Contract value 100% obligated
- $16,616.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, issued on September 2, 2025, by the Defense Logistics Agency, awards AmerisourceBergen Drug Corp a firm fixed-price contract valued at $16,616.60 for the supply of HUMIRA (CF) Pen 80 mg/0.8 mL, a pharmaceutical product used to treat autoimmune conditions. The contract represents a non-competitive set-aside award and will be performed at the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
As a child delivery order under the DLA's comprehensive pharmaceutical prime vendor contract, this award leverages AmerisourceBergen Drug Corp's established relationship as a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and broader military healthcare systems. The firm fixed-price structure and rapid completion timeline reflect the efficient delivery mechanism that characterizes DLA's medical supply chain operations for supporting federal healthcare requirements. AmerisourceBergen Drug Corp's extensive portfolio of federal contracts demonstrates its capacity to fulfill urgent pharmaceutical procurement needs across multiple therapeutic domains while maintaining compliance with federal contracting standards.
Quick answers
Who was awarded contract SPE2DB25FE4B8?
SPE2DB25FE4B8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FE4B8 worth?
The government has obligated $16,617 on SPE2DB25FE4B8.
Is contract SPE2DB25FE4B8 an order under another contract?
Yes. SPE2DB25FE4B8 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE4B8 competed?
The extent of competition for SPE2DB25FE4B8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award